Gould Capital »

Corcept Therapeutics Incorporated shares owned by Gould Capital

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Gould Capital from 13F filings

Historical chart of Gould Capital investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Gould Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Gould Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $16k 500 32.48
2023-09-30 $13k 500 26.29
2023-06-30 $11k 500 22.25
2023-03-31 $11k 500 21.66
2022-12-31 $10k 500 20.31
2022-09-30 $13k 500 26.00
2022-06-30 $12k 500 24.00
2022-03-31 $11k 500 22.00
2021-12-31 $10k 500 20.00

More positions owned by Gould Capital

Ishares 3-7 Year Treasury Bond Etf Etf (IEI)
Vanguard Total Bond Market Etf Etf (BND)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Total International Bond Etf Etf (BNDX)
Microsoft Corp Stock (MSFT)
Apple Stock (AAPL)
Intel Corp Stock (INTC)
Union Pac Corp Stock (UNP)
Spdr Gold Shares Etf (GLD)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Ishares Short Treasury Bond Etf Etf (SHV)
Caterpillar Stock (CAT)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Vanguard Ftse Emerging Markets Etf Etf (VWO)
Aflac Stock (AFL)

View all positions for Gould Capital

Top funds holding Corcept Therapeutics Incorporated

Vanguard Group
Ingalls & Snyder
Parallel Advisors
Dimensional Fund Advisors
Norden Group
Btim
Federated Investors
D. E. Shaw & Co
Arrowstreet Capital, Limited Partnership
Charles Schwab Investment Management
Man Group
Norges Bank Investment Management
Bank of New York Mellon
Millennium Management
Kynam Capital Management

View all funds holding Corcept Therapeutics Incorporated